Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 277-146-9 | CAS number: 72968-71-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Macrolex Rot B is a red powder with a molecular weight of 500 g/mole. The substance has a very low water solubility of < 3 µg/L at 20°C (Currenta, 2017) and a high log Kow (octanol/water) of +6.1 at 25°C (Currenta, 2016). No information is available on dermal bioavailability of the substance. However, based on the physical-chemical parameters given above dermal absorption can be expected to be very low if any (ECHA Guidance on Information Requirements, Chapter R7c, 2017).
Macrolex Rot B was tested for skin irritating effects in vivo in an acute dermal irritation test on rabbits (BASF, 1978). No irritation was reported on intact skin after 24 h exposure to 0.5 g of the compound moistened with water. In occupational settings no skin irritating or skin sensitizing effects were reported regarding human skin.
Based on this information no significant skin irritation was expected under the conditions of the Local Lymph Node Assay (LLNA) and it was assumed that the highest technically feasible compound suspension would be considered appropriate for this investigation.
However, in the mouse LLNA performed with the test item (OECD 429, radioactive method) it appeared that 5% of the test item in acetone/olive oil (4:1, v/v) was the highest applicable concentration avoiding local irritation determined in a pre-test on two mice. The 10% concentration led to slight ear swelling. No detailed information is given in the report on the effects seen in this pre-test. The main study was thus performed with the test item at concentrations of 1%, 2.5%, and 5% (w/v) in acetone/olive oil on 4 mice per group (Wang-Fan, 2004). No clinical signs or indications of local effects were seen after treatment. Lymph nodes were pooled and ³H-methyl thymidine activity was measured by beta-scintillation. Stimulation indices (S.I.) of 1.2, 1.4, and 1.4 were determined with the test item at the concentrations 1, 2.5 and 5%. The test item did thus not show a skin sensitizing potential when tested up to the concentration of 5%.
To clarify the discrepancy between the information gained via physical-chemical properties/skin irritation studies on the one side and the irritating effects observed in the LLNA on the other side, another pre-test for a LLNA was initiated (Dony, 2016). In this pre-test all tested concentrations (25, 10, 5 and 2.5%) induced excessive local skin irritation under the conditions of the LLNA using DMSO as vehicle. Ear thickness was increased by ≥ 23% on day 6 at 10, 5, and 2.5%. It is assumed that these irritant effects are related to the formulation of the test substance in DMSO and do not indicate irritating effects of the compound per se. Consequently, the study was stopped after the pre-test since testing the substance in the LLNA as suspension in DMSO will lead to artificial results and is not appropriate for human risk assessment.
Testing of Macrolex Rot B in chemico in the Direct Peptide Reactivity Assay (DPRA; OECD 442C) was technically not feasible. The substance was soluble in dimethyl sulfoxide/acetonitrile (1:1) but was insoluble in all other solvents that are acceptable for the DPRA. However, the dimethyl sulfoxide / acetonitrile 1:1 mixture itself had significant impact on the percent peptide depletion. The mean cysteine concentration of the reference control C (solvent control) was reduced by > 40%. Thus, the acceptance criteria for the DPRA were not fulfilled and no DPRA result for Macrolex Rot B could be obtained.
Testing of Testing of Macrolex Rot B in vitro for skin sensitization in the ARE-Nrf2 Luciferase Test (OECD TG 442D) and in the h-CLAT (OECD TG 442E) was also technically not feasible. The test article was insoluble in all suitable vehicles at sufficient concentrations to meet the OECD Test Guidelines for both tests. It was thus concluded that the test article is outside of the applicability domain for these studies and the tests could thus not be performed.
In conclusion, based on the available phys-chem data and the LLNA results of the test item in acetone/olive oil Macrolex Rot B is considered to exert no skin sensitizing potential. This conclusion is in line with in silico results obtained via OECD QSAR Toolbox (version 4.0) that show no structural alert for skin sensitization for Macrolex Rot B (Schlecker, 2017).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
- Remarks:
- no quantitatative data is given for the effects in the pre-test;
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2002
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2004
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- Name of test material given in the report: Sandoplast Red BB
appearance: red solid
purity: 98.5% - Species:
- mouse
- Strain:
- CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands, B.V. Postbus 6174, NL-5960 AD Horst, The Netherlands
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known:
- Age at beginning of acclimatization: 8-12 weeks
- Weight: 16 - 24 g
- Housing: individually
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C (plus/minus 3°C)
- Humidity (%): 30-70%
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12h
- IN-LIFE DATES: From: 15.09.2004 To: 29.09.2004 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- non-GLP pre-test: 1, 2.5, 5, and 10%
GLP main test: 1, 2.5, and 5% - No. of animals per dose:
- 4
- Details on study design:
- PRE-SCREEN TESTS:
- Irritation: in a non-GLP pretest in two mice test item concentrations of 1, 2.5, 5, and 10% (w/v) were tested on one ear each; after a single application no irritation effects were observed up to the concentration of 5%; slight ear swelling was noted 24 hours after treatment at the local site dosed at 10%
- Ear thickness measurements: slight ear swelling was noted 24 hours after treatment at the local site dosed at 10%; thus, 5% was determined as the highest applicable concentration while avoiding systemic toxicity and excessive local irritation in the chosen vehicle.
MAIN STUDY
Test item preparation: The weight/volume dilutions were prepared individually using a magnetic stirrer as homogenizer. The test item formulation were made freshly before each dosing occasion and no more than 4 hours prior to application to the ears. Homogeneity of the test item in the vehicle was maintained during treatment with the magnetic stirrer.
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: radioactive LLNA
- Criteria used to consider a positive response:
A test item is regarded as a sensitizer in the LLNA if the following criteria are fulfilled:
- first, exposure to at least one concentration results in ³HTdR incorporation of at least 3-fold over control mice as indicated by the Stimulation Index (S.I.)
- second, data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression
TREATMENT PREPARATION AND ADMINISTRATION:
Treamtent: Mice were treated topically on the dorsal surface of each ear lobe with the test item concentrations 1, 2.5 and 5% (w/v) in acetone/olive oil (4:1). The application volume (25 µL) was spread over the entire dorsal surface of the ear lobes once daily for 3 consecutive days. A hair dryer was passed briefly over the ear's surface to prevent the loss of any test item applied.
Administration of ³H-Methly Thymidine: (specific activity 2Ci/mmol, concentration 1 mCi/mL) five days after the first topical application all mice were administered with 250 µL of 76.6 µCi/mL ³HTdR (equal to 19.1 µCi) by intravenous injection via a tail vein.
Determination of ³HTdR: approximately 5 hours after treatment with ³HTdR all mice were euthanized by inhalation of CO2. Draining lymph nodes were excised and pooled for each experimental group (8 nodes per group). The level of ³hThR incorporation and background activity were measured on a beta-scintillation counter (disintegration per minute, DPM). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- mean values and standard deviations were calculated for the body weights
- Positive control results:
- Stimulation indices of 2.7, 3.4, and 12.4 were determined for the positive control in concentrations of 5, 10, and 25%. The positive control was thus found to be a skin sensitizer and an EC3 value of 7.1% (w/v) was derived.
- Parameter:
- SI
- Value:
- 1.2
- Test group / Remarks:
- 1%
- Parameter:
- SI
- Value:
- 1.4
- Test group / Remarks:
- 2.5%
- Parameter:
- SI
- Value:
- 1.4
- Test group / Remarks:
- 5%
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
no data given on cellular proliferation
DETAILS ON STIMULATION INDEX CALCULATION
DPM were calculated for pooled lymph nodes (8 per group) and the DPM per lymph node were calculated by dividing the measured value by the number of lymph nodes pooled.
The DPM per lymph node is given with 351 for the control and 417, 484, and 508 for the treatment groups 1%, 2.5%, and 5%.
EC3 CALCULATION
Calculation of EC3 could not be done because no test concentration produced a S.I. of 3 or higher
CLINICAL OBSERVATIONS:
No symptoms of local toxicity at the ears and no systemic findings were observed during the study.
BODY WEIGHTS
Body weights were within the range of the control with the exception of two mice (one in the 1% and 5% group each) that lost weight during the study. This was considered to be incidental. - Executive summary:
A radioactive mouse LLNA (OECD 429) was performed with the test item at concentrations of 1%, 2.5%, and 5% (w/v) in acetone/olive oil (4:1, v/v) on 4 mice per group. 5% was the highest applicable concentration avoiding local irritation determined in pre-test in two mice. Treatment occurred on 3 consecutive days. ³H-methyl thymidine was injected intravenously on day 5.
No clinical signs or indications of local effects were seen after treatment. Lymph nodes were pooled and ³H-methyl thymidine activity was measured by beta-scintillation. Stimulation indices (S.I.) of 1.2, 1.4, and 1.4 were determined with the test item at the concentrations 1, 2.5 and 5%. The test item did thus not show an allergenic potential when tested up to the concentration of 5%.
Reference
Justification for classification or non-classification
Based on the available phys-chem data and the LLNA results of the test item in acetone/olive oil Macrolex Rot B is considered to exert no skin sensitizing potential. This conclusion is in line with in silico results obtained via OECD QSAR Toolbox (version 4.0) that show no structural alert for skin sensitization for Macrolex Rot B (Schlecker, 2017). Thus, no classification is warranted for skin sensitization.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.